SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-30
👔
Monopar Therapeutics
@MNPR_InsiderForm 4 Filing: Sweeny Nicole Acquires (Grant) shares of $MNPR
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Monopar Therapeutics
Ticker: $MNPR
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-06-26
Shares: 1,284
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Sweeny Nicole, holds the title of Director at Monopar Therapeutics.
On 2026-06-26, the insider transacted 1,284 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Sweeny Nicole (Director) was granted $0 of $MNPR
Post-Transaction Position: 1,284 shares
SEC Accession No: 0001437749-26-022164 (CIK: 1827505)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.